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Abstract
Background: Although South Asians (SA) form a large majority of the Asian population of U.S.,
very little is known about cancer in this immigrant population. SAs comprise people having origins
mainly in India, Pakistan, Bangladesh and Sri Lanka. We calculated age-adjusted incidence and time
trends of cancer in the SA population of California (state with the largest concentration of SAs)
between 1988–2000 and compared these rates to rates in native Asian Indians as well as to those
experienced by the Asian/Pacific Islander (API) and White, non-Hispanic population (NHW)
population of California.
Methods: Age adjusted incidence rates observed among the SA population of California during the
time period 1988–2000 were calculated. To correctly identify the ethnicity of cancer cases, 'Nam
Pehchan' (British developed software) was used to identify numerator cases of SA origin from the
population-based cancer registry in California (CCR). Denominators were obtained from the U.S.
Census Bureau. Incidence rates in SAs were calculated and a time trend analysis was also
performed. Comparison data on the API and the NHW population of California were also obtained
from CCR and rates from Globocan 2002 were used to determine rates in India.
Results: Between 1988–2000, 5192 cancers were diagnosed in SAs of California.
Compared to rates in native Asian Indians, rates of cancer in SAs in California were higher for all
sites except oropharyngeal, oesophageal and cervical cancers. Compared to APIs of California, SA
population experienced more cancers of oesophagus, gall bladder, prostate, breast, ovary and
uterus, as well as lymphomas, leukemias and multiple myelomas. Compared to NHW population
of California, SAs experienced more cancers of the stomach, liver and bile duct, gall bladder, cervix
and multiple myelomas. Significantly increasing time trends were observed in colon and breast
cancer incidence.
Conclusion: SA population of California experiences unique patterns of cancer incidence most
likely associated with acculturation, screening and tobacco habits. There is need for early diagnosis
of leading cancers in SA. If necessary steps are not taken to curb the growth of breast, colon and
lung cancer, rates in SA will soon approximate those of the NHW population of California.
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The south Asian (SA) population of United States was
1,893,723 in the year 2000 [1], and between 1990 and
2000 this population grew in size by 106%. Persons with
origins in India, Pakistan, Bangladesh, and Sri Lanka are
classified as SA and they are now the third largest Asian
subgroup in the United States, comprising 16% of all U.S.
Asians. Approximately 21% of SAs in the U.S. reside in
California, the state with the largest concentration of SAs.
From 1990 to 2000, the number of SAs living in Califor-
nia increased from 168,457 to 343,731 (104% increase)
[2,3]. 90% of SAs are Asian Indian (people with origins in
India). In the year 2000 the SA population of California
comprised 1.15% of the total population and this propor-
tion is increasing.
There are no published studies on the incidence of cancer
among SAs in United States, except for one study which
reported breast and colon cancer incidence in Asian Indi-
ans and that analysis was based on a very small sample
size [4]. Another study by Divan et al. reports the current
available literature on this issue and emphasizes the need
to conduct more studies on cancer incidence and mortal-
ity [5]. The reason for lack of cancer studies in this popu-
lation may be multiple; including controversy regarding
which communities are included under the title 'South
Asian', the relatively recent growth of this community in
the US, and the belief that SAs are part of a 'model minor-
ity' and therefore have better health status than other
minority groups. In previous studies all Asians have been
grouped into one category, which may mask important
differences in incidence and survival among various sub-
groups.
Most of the cancer studies in SAs residing outside of south
Asia have been done in the UK or Canada [6]. Many can-
cer studies have been conducted in the SA population of
UK, mainly because they form the largest ethnic minority
of UK. Much attention has been focused on breast and
lung cancer epidemiology [7-11]. Studies focusing on
multiple cancer sites are few [11,12] although some atten-
tion has been given to childhood cancers, mainly because
childhood cancers are increasing with time [13-16].
Initial studies suggested that English SA rates for all sites
combined were lower than the non-SA rates but higher
than Indian subcontinent rates (especially for lung cancer
in males, breast cancer in females, and lymphomas in
both sexes). But a sub-site analysis revealed that, English
South Asian rates were significantly higher than the non-
SA rates for Hodgkins disease in males, and oral, esopha-
geal, thyroid, leukemias in females, and cancers of the
pharynx, liver and gall bladder in both sexes [12].
Recent studies in UK indicate, that younger SA, particu-
larly children are at increased risk of cancer than the non-
SA population and although generally cancer rates have
fallen over the last decade, they are increasing among SAs
[11].
Studies on cancer in the SA population of Canada pertain
primarily to cancer screening, and no studies on cancer
incidence have been reported [17,18].
Studies of cancer incidence in immigrant populations can
provide valuable insights into etiology and changes
towards the pattern of disease seen in the host country
may indicate environmental factors in etiology [19].
Therefore, in this analysis we have calculated age adjusted
rates for cancer in the SA population of California and
compared these rates to native Asian Indians (people liv-
ing in India) as well as the Asian/Pacific Islander (Asian/
PI) and non-Hispanic White (NHW) populations of Cali-
fornia in the same time period. We also conducted a time
trend analysis to study the patterns of cancer incidence in
this population for the period 1988–2000. Where appro-
priate, we have also compared these rates to those
reported in Great Britain.
Methods
The California Cancer Registry (CCR), a population-based
registry, commenced operation in 1988. The methodol-
ogy of the CCR has been fully described by Morris et al.
[20]. The CCR collects information on all cancers except
for non-melanoma skin cancers and in situ cancers of the
uterine cervix. Information on several demographic varia-
bles, diagnostic variables (including stage at diagnosis,
tumor size, histology and grade of tumor), and first course
of treatment are collected for all cases. Cases are routinely
coded with regard to anatomic stage of disease using the
general summary stage schema for 1988–1993 [20], and
SEER extent of disease for 1994–1997 [21]. Race and eth-
nicity are categorized into four mutually exclusive groups
in the CCR database: White, non-Hispanic, Black, non-
Hispanic, Hispanic, and Asian/Pacific Islander. Under the
last category there are further breakdowns for several
Asian ethnic groups, including the category 'Asian Indian/
Pakistani', which includes people of SA origin.
Our analysis included cancer cases diagnosed during the
period 1988–2000. Incidence rates were calculated for
this population for all major sites and several specific can-
cer types. Due to small numbers for some of the cancer
sites, the rates for individual years were grouped into
three-year categories to reduce the instability of rates. In
addition, an age-adjusted trend analysis of the rates was
completed for the period 1988–2000 to determine the
Annual Percentage Change (APC) (using the non-Page 2 of 13
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APCs.
Ethnic Classification
The SA group is heterogeneous, not only in national ori-
gin, sub-ethnicity (and therefore heritable features), and
religion, but also in specific details of pertinent lifestyle
including alcohol, tobacco, and various levels of vegetari-
anism. Secondly, individual hospitals, from where most
cancer cases are identified by the CCR, do not have the
resources to correctly categorize race/ethnicity. Hence
many SA cancer patients may be classified as "Asian, not
otherwise specified" by the hospital.
Due to the above situation, a British developed software
program called 'Nam Pehchan' [22] (literally means name
identification in Hindi) was used in this study in order to
address the issue of misclassification of race/ethnicity.
This software is a computer program for the identification
of names, which originate in the Indian subcontinent and
Sri Lanka, which collectively we call here "South Asia". It
provides a reasonably accurate way of identifying people
belonging to "South Asian" and "Other" ethnic groups. It
also identifies the religious and linguistic origins of the
names where possible. Both surnames and forenames can
be matched against the program's stored lists. Given the
possibility that different elements of a name may meet
with varying recognition from the lookup table, the final
result is not simply "South Asian" or "not South Asian",
but rather a numeric code indicating the outcome of the
search and match process. Knowing the limitations of this
program [23], we used this software program, as well as
birthplace and a visual case-by-case review to correctly
identify approximately 5,200 cancer cases of SA origin,
from the 106, 653 Asian/Pacific Islander cancer database
at CCR, 1988–2000. We identified 30% more SA cases as
compared to CCR (CCR identified approximately 4000 SA
cases in the same time period).
Calculation of incidence rates
Numerators, comprised of all newly diagnosed cancer
cases, were derived by applying the Nam Pehchan soft-
ware to all cancer cases classified as Asian/Pacific Islander
by the CCR, 1988–2000. The numerators were coupled
with age, gender and yearly specific denominator data for
the SA population in California (population counts)
obtained from the U.S. Census Bureau. Detailed popula-
tion counts and demographic characteristics for SA sub-
groups for both the 1990 and 2000 decennial census are
available from the US Census Bureau [2,24]. Electronic
population data by age and sex for all SA subgroups were
identified and obtained. Hard copy population data for
the California 1990 SA subgroups were also identified and
key-entered and are available at the cancer registry. Using
these census data sets, interpolation between the two
decennial censuses was completed and extrapolation back
to the years 1988 and 1989 was completed to create the
best estimates of the SA subgroups at risk on an age and
sex specific basis. The interpolation and extrapolation was
done assuming a linear growth in the SA population sub-
groups. Finally, the subgroup estimates were combined
on an age and sex specific basis for each individual year
from 1988–2000 to form one SA population group for
each individual year. Using these data age-specific and
age-adjusted cancer incidence rates were calculated for the
time period 1988–2000. We used the 2000 U.S (5-year
groups) population as the standard population.
For purpose of comparison between cancer rates in native
Asian Indians (living in India) and SAs in California, we
calculated Age Standardized Rates (ASRs), using the world
standard for the California SAs and compared them to
ASRs in India, obtained from the Globocan 2002 [25].
Globocan is a publication of the International Association
of Research for Cancer (IARC), and rates for India are for
the time period 1993–1997, and cover eight regional reg-
istries in India. We used rates from India as our compari-
son parameter, as 90% of SAs in the U.S. are of Asian
Indian origin. In addition, we calculated incidence rate
ratios (IRRs) by taking a ratio of California SA ASRs and
Indian ASRs, calculated Confidence Intervals (CIs) and
determined the significance [26].
Grouped analysis
Rates for the period of 1988–2000 were divided into 4
time periods by grouping the years of diagnosis into four
categories, namely 1988–1991, 1992–1994, 1995–1997
and 1998–2000. Incidence rates were calculated for each
of these time periods. We also compared these rates to the
Asian/PIs as well as the NHW population of California for
the same time periods.
Time Trend analysis
We performed a time trend analysis for each of the cancer
sites separately for males and for females, using the 'age-
adjusted trend analysis' feature of SEER-STAT [27]. For
this purpose, we used the annual data versus the catego-
rized grouped data. We calculated the Annual Percentage
Change (APC) (identifies the percent change by comput-
ing the slope of the best-fitting regression line around the
data points-rates for each individual years in this case)
and p-values for APCs.
Results
In total, 5192 cases of cancer were diagnosed in SA popu-
lation of California between 1988–2000, including 2411
males, and 2781 females. The median age at diagnosis of
cancer was 63 years in males and 54 years in females. A
comparison of overall age-adjusted invasive cancer inci-
dence rates for the three ethnic groups revealed that the SAPage 3 of 13
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pared to 325.2/100,000 for Asian/PI and 489.1/100,000
for NHW (Figure 1). In the recent years the overall inva-
sive cancer rates for California SAs have been higher than
those of the Asian/PIs of the state.
Table 1 summarizes the cancer counts by major cancer
sites and Figures 2 and 3 show the top five leading cancers
and their trends in the SA males and females respectively.
Leading cancers in SA males include prostate, colorectal,
urinary system, lung and bronchus, and lymphomas. The
leading cancer in SA females is breast cancer followed by
colorectal, uterine, ovarian and cervical cancer. In this sec-
tion we have categorized cancers into two groups namely;
common cancers (cancers common to males and females)
and gender specific cancers (reproductive organ cancers).
Comparison of cancer incidence between California SAs 
and native Asian Indians
Age standardized rates for California SAs and those for
India as well as Incidence Rate Ratios (with statistical sig-
nificance) are presented in Table 2. IRR of more than one
indicates that California SAs are at higher risk of develop-
ing that particular cancer than the native Asian Indians.
Overall, California SA males and females are at double
risk for developing cancer than native Asian Indians.
Common cancers
California SAs were at lower risk of oropharyngeal and
esophageal cancers than the native Asian Indian popula-
tion, which occur very commonly in India. The California
SA population was at higher risk for gastrointestinal can-
cers (namely colorectal, hepatic, and pancreatic cancers).
They were also at higher risk for hematopoietic and lym-
phoreticular and endocrine malignancies. The SA popula-
tion of California also experienced a higher risk for other
organ systems such as, urinary system and brain & CNS
cancers.
Gender specific cancers
SA men experienced 15 fold risk of prostate cancer than
the native Asian Indian population. California SA females
experienced higher risk of all reproductive organ cancers
except cervical cancer.
Comparison of incidence rates between SAs and Asian/PIs 
of the state of California
Incidence rates and time rends between 1988–2000, for
California SAs as well as the Asian/PI and NHW popula-
tion are presented in Table 3 and Table 4.
Common cancers
In general, the SA population of California experienced
more brain & CNS cancers, hematopoietic and lymphore-
ticular cancers than the Asian/PI population of the state.
SA females also experienced higher oropharyngeal,
esophageal and gall bladder cancer than the Asian/PI
women of California. As regards to other cancer sites, the
SA population of California was at equal or lower risk
than the Asian/PIs of the state.
Gender-specific cancers
SA males experienced more prostate cancer than the
Asian/PI males and SA females experienced more repro-
ductive organ cancers than the Asian/PI women, except
for cervical cancer.
Comparison of SA rates with NHWs of the state
Common cancers
The SA population of California experienced more Gastro
Intestinal cancers (mainly hepatic, gall bladder and stom-
ach cancers) and myelomas than the NHW population of
the state. SA females experienced more oropharyngeal and
esophageal cancers than the NHW women. SA males
experienced recent increase in leukemia incidence as com-
pared to the NHW males.
Gender specific cancers
As far as the reproductive cancers are concerned, the SA
population was at lower risk of these cancers than the
NHW population of the state, except for cervical cancer.
Trends over time
Overall, SA males experienced a decreasing trend of all
cancers combined, over the time period of 1988–2000
(APC = -1, p = 0.2), while SA females experienced an
increasing trend (APC = 0.9, p = 0.4). Table 5, shows the
Comparison of invasive cancers, all sites combined, in the SA1, NHW2 and API3 population of California, 1988–2000Figure 1
Comparison of invasive cancers, all sites combined, in the 
SA1, NHW2 and API3 population of California, 1988–2000. * 
Rates are per 100,000 and age-adjusted to the U.S. 2000 
standard population (18 age groups). 1 south Asian. 2 White, 
non-Hispanic. 3 Asian/Pacific Islanders.Page 4 of 13
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SA population.
Common cancers
The SA population of California experienced a signifi-
cantly decreasing trend of oropharyngeal cancers. On the
other hand they experienced an increasing trend of
hepatic and renal cancers. In addition, SA males experi-
enced an increasing trend of hematopoietic & lymphore-
ticular cancers (NHL, multiple myelomas, leukemias) and
brain & other CNS cancers. SA females experienced an
increasing trend of gastrointestinal cancers (esophageal
colon, hepatic, and stomach), lung and thyroid cancers.
Gender-specific cancers
As far as the reproductive organs were concerned, SA
females experienced an increasing trend of breast and
uterine cancers. All other sites experienced either a
decreasing or steady trend over time.
Discussion
The present study reveals several unique cancer patterns
among SAs in California. Firstly, the median age at diag-
nosis of cancer in this population is 58 years compared to
68 years for all other races [28]. Secondly, the most com-
mon cancers in the Indian subcontinent are not the most
common cancers in SAs of California. The most common
cancers among men in India are oral cavity and pharynx,
lung, esophagus, laryngeal and stomach cancers [25]. In
India, cervical cancer is most common in women, fol-
lowed by breast, oral cavity, esophagus and ovarian cancer
[25]. In India about half the cases among men and one-
fifth cases among women are in cancer sites affected by
tobacco use (tobacco smoking as well as tobacco chew-
ing) [29], which was not seen in SAs of California.
Common cancers (cancers common to both males and 
females)
Oropharyngeal cancers
Our findings indicate that California SAs are at lower risk
of oral and esophageal cancers than the native Asian Indi-
ans. This directly reflects the general tendency of the SA
immigrants to avoid use of tobacco products (especially
chewing 'paan' (tobacco rolled up in betel nut leaves) and
smoking 'bidi' (cigarette made out of tobacco leaves, with
no filters) in a foreign country. Besides, majority of SA
immigrants in California tend to be educated and do not
have such habits even in South Asia.
Esophagus cancer
Esophageal cancer is increasing in SA females and is
higher than both NHW and Asian/PI females. Such find-
ings of increasing trend are not seen in the SA males. This
finding also seems contradictory to the general decreasing
trend of oropharyngeal cancers, as esophageal and
oropharyngeal cancers share similar etiologies. The etiol-
ogy of esophageal cancer is mainly associated with con-
sumption of tobacco (smoking or smokeless) and
Table 1: Cancer counts in the south Asian population of California, by cancer sites, 1988–2000.
Male and female Male Female
All Sites 5,192 2,411 2,781
Oral Cavity and Pharynx 160 95 65
Esophagus 52 26 26
Stomach 128 71 57
Colon and Rectum 471 285 186
Liver and Intrahepatic Bile Duct 104 70 34
Gallbladder 48 12 36
Pancreas 83 47 36
Lung and Bronchus 296 188 108
Skin excluding Basal and Squamous 61 38 23
Breast 981 6 975
Cervix Uteri 270 0 270
Corpus and Uterus 145 0 145
Ovary 155 0 155
Prostate 661 661 0
Testis 34 34 0
Urinary System 244 189 55
Brain and Other Nervous System 141 76 65
Thyroid 148 41 107
Hodgkin Lymphoma 56 32 24
Non-Hodgkin Lymphoma 247 143 104
Myeloma 86 49 37
Leukemia 225 138 87Page 5 of 13
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tion, reflux disease also play an important role in etiology
of esophageal cancer [30,31]. There are no published
studies about smoking/tobacco/alcohol use prevalence in
the SA population in the U.S. Because of lack of such data
we cannot correlate our findings with the smoking preva-
lence. The rise of esophageal cancer in California SA
females as well as histological subtype evaluation of this
cancer is needed.
Stomach cancer
IRRs suggest that California SA females are at a higher risk
for stomach cancer than native Asian Indian females, but
this is not true for males. The time trend analysis suggests
that male stomach cancer is decreasing, but female stom-
ach cancer is on the rise. Infections with Helicobacter
pylori and genetic predisposition of host have been sug-
gested to be the most important causes of stomach cancer
in general population [32,33].
Cancers of the liver and intrahepatic bile duct
These cancers are of common occurrence in Asians. HBV
(hepatitis B virus) infection, with and without aflatoxin
exposure, and alcoholic liver cirrhosis are responsible for
most cases of hepatocellular cancer in developing coun-
tries [34]. There is widespread contamination of foods
with aflatoxin and moderately high prevalence of HBV
and hepatitis C (HCV) virus-related chronic liver disease
in India [35]. IRRs suggest that California SA population
is at higher risk (more than two-fold) of hepatic cancers
than native Asian Indians. Our findings are similar to the
studies done in the past in UK on migrants of Indian eth-
nicity as well as British ethnicity, to the UK [16,36].
Gall bladder cancer
The major causative factors for gall bladder cancer include
gallstones and genetic susceptibility, and liver flukes in
Asian countries have also been suggested to be causative
[37]. In one study done in India, the prevalence of gall-
stones in adult population was 6.12% (3.07% in males,
9.6% in females) [38]. All these above stated factors could
explain our finding of much higher rates in the SA popu-
lation than Asian/PI or NHW population. Similar findings
have been reported by studies in SA immigrants to the UK
[12,36,39]. Nevertheless, it is encouraging that there is a
significantly decreasing trend of this cancer in California
SAs.
Colon and rectal cancer
Both SA males and females of California experienced
more than four-fold risk of developing this cancer com-
pared to the native Asian Indian population. Studies in
the general population estimate that 13% of this cancer
can be attributed to being physically inactive, 12% to eat-
ing a Western style diet, and 8% to having a first degree
relative with colorectal cancer [40]. The diet of Asian Indi-
ans in the United States has changed from one featuring
low-fat, high-fiber foods to one characterized by higher-
fat animal protein, low fiber, and high levels of saturated
fat. There is an increased tendency among Asian Indians
in America to consume fast foods and convenience foods
[41]. The significantly rising trend of colon cancers seen in
SA females, which is otherwise a low-risk population, may
be related to migration and subsequent acculturation and
adoption of Western diet and lifestyle.
Top five leading cancers with trends in California south Asian females, 1988–2000Figure 3
Top five leading cancers with trends in California south Asian 
females, 1988–2000. * Rates are per 100,000 and age-
adjusted to the U.S. 2000 standard population (18 age 
groups).
Top five leading cancers with trends in California south Asian males, 1988–2000Figure 2
Top five leading cancers with trends in California south Asian 
males, 1988–2000. * Rates are per 100,000 and age-adjusted 
to the U.S. 2000 standard population (18 age groups).Page 6 of 13
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As compared to the native Asian Indian rates, the SAs of
California are at higher risk for this cancer. The five-fold
risk in California SA females as compared to the native
Asian Indian females and an increasing trend is notewor-
thy. A decreasing trend of lung cancer in SA males is not
in concordance with a recent study done in the UK SA
population, which reports recent increase in incidence of
lung cancer in both SA men as well as women [7].
Non-Hodgkin's Lymphomas (NHL)
IRRs suggest that the California SAs are at a much higher
risk (3–6 fold higher risk) of developing NHL than native
Asian Indians. In addition, an increasing trend of NHL has
been observed in the SA population of California. While
the incidence of NHL has doubled in the U.S., etiology of
lymphomas remains elusive. Epidemiological studies sug-
gest the role of hereditary factors, immunosuppression,
viruses (HIV, EBV, HTLV, H.pylori, HHV8, HCV), chemi-
cal and agricultural exposures and other factors in the eti-
ology of NHL [42]. Recent studies have also associated
menstrual and reproductive factors (higher parity and
early menarche offer a protective effect for NHL) with risk
of NHL [43,44]. Lack of immune stimulation/challenge
('hygiene hypothesis') [45] and acculturation could
explain the higher risk seen in this population.
Leukemias
Three-fold higher risk of developing leukemias in Califor-
nia SAs as compared to the native Asian Indians, and a ris-
ing trend of this cancer over time shows similarity with
results from UK SA studies [14,16,19]. Types of leukemias
and their causes vary widely and are age dependant. Fur-
ther investigation, especially age specific and leukemia
subtype analysis is needed into this finding.
Multiple myelomas
IRRs suggest that California SA population experience a
much higher risk (four-five fold) of developing myelomas
than the native Asian Indians, as well as higher rates than
the Asian/PI or NHW population of California. Risk fac-
tors for multiple myelomas include, monoclonal gam-
mopathy of unknown significance, chronic immune
stimulation (as in infections with tuberculosis, malaria,
hepatitis, etc.), autoimmune disorders, and occupational
exposures [46]. Every year, approximately two million
persons in India develop tuberculosis, and incidence of
malaria is 2–3 million cases per year [47,48]. Exposure to
these chronic diseases before migration could explain the
high rates of myelomas seen in California SAs.
Findings of elevated risk of haematopoietic and lym-
phoreticular malignancies (lymphomas, leukemias and
Table 2: IRRs and site specific cancer ASRs in India and South Asians in California, 1993–1997.
SITE SOUTH ASIAN MALES SOUTH ASIAN FEMALES
India ASR1 California ASR2 IRR3 India ASR California ASR IRR
All Sites 99 199.6 2.0 104.4 195.7 1.9
Oral Cavity 12.8 5.1 0.4 7.5 4.6 0.6
Esophagus 7.6 2.6 0.3 1.9 2.4 1.3
Stomach 5.7 6 1.1 2.8 5.2 1.9
Colon and Rectum 4.7 22.8 4.9 3.2 13.4 4.2
Liver & Intrahepatic Bile Duct 2.3 5.3 2.3 1.1 3.1 2.8
Pancreas 1.4 4.5 3.2 0.8 4.5 5.6
Lung and Bronchus 9 13.9 1.5 2 9.9 5.0
Prostate 4.6 69.9 15.2 ~ ~ ~
Breast ~ ~ ~ 19.1 66.6 3.5
Cervix Uteri ~ ~ ~ 30.7 8.4 0.3
Corpus Uteri ~ ~ ~ 1.7 10 5.9
Ovary ~ ~ ~ 4.9 10.4 2.1
Urinary Bladder 3.2 9.4 2.9 ~ ~ ~
Kidney and Renal Pelvis 1.2 4.9 4.1 0.5 2.4 4.8
Brain & other CNS 2.6 5.4 2.1 1.6 3.6 2.3
Thyroid 1 1.5 1.5 1.9 7.6 4.0
Non-Hodgkin Lymphoma 3.2 11.2 3.5 1.7 10.3 6.1
Myeloma 1 4.6 4.6 0.6 3.1 5.2
Leukemia 3.1 9.9 3.2 1.9 6.8 3.6
1Rates for India obtained from Globocan 2002, rates are an average of 8 regional cancer registries (1993–1997).
2 Age standardised rates (world population), rates are per 100,000 population.
3 Incidence Rate Ratios, ratio of rates in SAs in California vs Indian cancer rates.
IRRs in bold indicate significantly elevated IRRs in California SAs (p < 0.05).
~ indicates cases less than 10 for California SAs, hence rates are not significant enough to report.Page 7 of 13
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Males Females
Cancer site time period SA API NHW SA API NHW
oral cavity and pharynx 1988–1991 14.6 13.2 20.6 11 7.1 9
1992–1994 8.3 12.9 19.5 8.2 6.8 8.2
1995–1997 11.7 13.2 18.9 6.4 6 8.1
1998–2000 7.7 11.8 17.7 8 6 7.2
esophagus 1988–1991 7.9 6.3 6.4 2 1.4 2.3
1992–1994 1.9 4.8 6.8 4.1 1.2 2.1
1995–1997 5.7 4.9 7.2 3.9 1.1 2.3
1998–2000 4.1 3.4 7.5 6 1.4 2.3
stomach 1988–1991 16.6 24.9 12.9 4.9 15.9 5.4
1992–1994 8.6 24.9 11.4 7.6 15.5 4.6
1995–1997 11.8 24.2 11 9.8 13.8 4.4
1998–2000 10.8 20.5 9.7 10 12.2 4.4
liver and intrahepatic bile duct 1988–1991 10.4 21.6 4.2 5 7.2 1.9
1992–1994 11 22.6 5 4.3 9.2 2.1
1995–1997 9.8 24.4 5.6 5.3 9.1 2.3
1998–2000 10.4 24.5 6.3 6.4 8.5 2.5
gall bladder 1988–1991 1 1.6 0.8 9.4 3.3 1.2
1992–1994 1.9 1.6 0.7 9.1 2.4 1.1
1995–1997 2.4 1.5 0.6 3.2 2.2 1.1
1998–2000 1.2 1.2 0.6 3.6 1.8 1.1
pancreas 1988–1991 6.3 12.4 13.3 6.6 8.6 10.2
1992–1994 4.4 11 12.8 7.3 6.6 9.9
1995–1997 7.4 9.6 12.5 6.9 7.9 9.4
1998–2000 10.6 8.9 11.8 3.2 7.5 9.5
lung and bronchus 1988–1991 33.5 65.3 101.9 19 28.3 59.3
1992–1994 26.8 64.7 92.6 21.7 26.9 59.5
1995–1997 18.5 60.8 86.5 18 28.4 60
1998–2000 35.2 59 79 27 27.3 57.2
colon and rectum 1988–1991 42.6 57 78.8 24.6 41.9 54.6
1992–1994 36.8 58.5 71.4 21.5 39.6 49.3
1995–1997 46.2 58.3 67.7 24.6 39.1 47.9
1998–2000 35.6 52.4 64.1 34.5 40.1 46.7
brain and other CNS (central nervous system) 1988–1991 8.2 4 9.4 7.4 3.6 6.5
1992–1994 10.5 4.7 9.1 5.7 3.7 6.4
1995–1997 3.7 3.8 8.9 3.9 3.3 6.1
1998–2000 7.3 4 8.8 8.3 2.6 6.1
urinary bladder 1988–1991 22.3 15 43.5 5.2 4.4 10.7
1992–1994 14.8 17 42.3 1.6 4.3 9.9
1995–1997 18 14.8 41.2 3 4.4 10.1
1998–2000 18.6 15.1 40.9 3.2 3.7 9.9
kidney and renal pelvis 1988–1991 8.8 6.6 14.6 2.8 3.8 6.8
1992–1994 6.2 7 14.2 3.3 3.4 7
1995–1997 7.9 8.3 14.8 3.2 3.9 7.3
1998–2000 12.5 8.1 14.8 3.8 3.7 7.2
endocrine (thyroid) 1988–1991 4 4.2 4.2 7.6 9.7 7.7
1992–1994 1.3 4.7 3.9 8.7 11.2 8
1995–1997 2.2 4.6 4.1 9.4 11.5 8.8
1998–2000 3.2 4.3 4.5 8.5 12.4 10.2Page 8 of 13
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tion. Similar results have been reported in SA immigrants
of UK [12,16,36].
Thyroid cancer
IRRs indicate that California SA females are four times
more likely to get thyroid cancer than Indian females; this
is not true in males. The incidence of congenital hypothy-
roidism and prevalence of goiter in India is much higher
than the worldwide average [49]. A large fraction of the
Indian population suffers from iodine deficiency disor-
ders [50]. The major etiological factors for thyroid cancers
have been iodine deficiency and ionizing radiation [51-
53]. We cannot explain the higher IRR observed in Cali-
fornia SA females.
Brain and other nervous system cancers
California SAs experienced higher IRRs of these malignan-
cies as compared to native Asian Indians. SA males expe-
rience higher rates of these malignancies than the Asian/
PIs and SA females recently experienced higher rates than
Asian/PIs as well as NHWs. This finding is not in concord-
ance with the other studies done in the UK SA population
[14,16]. These cancers are infrequent in India and fre-
quent amongst the U.S. Whites, making the SA popula-
tion a low-risk population [54,55]. In spite of being a low-
risk population, higher IRRs and rates of these cancers
observed in SAs need further investigation.
Gender-specific cancers
Prostate cancer
Prostate cancer is the most common cancer in SA males
and has increased from 1988–2000. California SA males
experienced fifteen fold-increased risk of this cancer as
compared to Indian males. Also, rates are higher in Cali-
fornia SA males than in Asian/PIs of California. Epidemi-
ological studies suggest that endogenous risk factors like
family history, androgens, race, aging, oxidative stress and
exogenous factors including diet and environmental
agents have been associated with this cancer [56]. Other
studies suggest that screening for this cancer has dramati-
cally increased the number of men with local disease at
diagnosis [57]. The fifteen-fold risk of prostate cancer in
this population as compared to the native Asian Indians
could be explained by early detection (measurement of
serum PSA), rather than true differences in underlying
risk. The other factors explaining this difference could be
lead-time, case identification, detection and reporting
biases.
Breast cancer
Breast cancer is the number one cancer in the California
SA females and they are 3.5 times more likely to develop
this cancer as compared to native Asian Indian females.
Our time-trend analysis suggests that, although in situ
breat cancer diagnosis has significantly increased, invasive
breast cancer diagnosis has increased alarmingly more in
non-Hodgkins lymphoma 1988–1991 11 15.8 24.4 10.5 10.6 14.6
1992–1994 13.8 16.7 25.7 16.2 10.6 14.7
1995–1997 15.2 15.9 25.7 14.7 10.7 15.7
1998–2000 21.1 15.7 23.3 11 11.4 15.9
Hodgkins lymphoma 1988–1991 2 1.5 3.6 1.5 0.6 2.8
1992–1994 2.4 1.5 3.4 1.9 0.8 2.7
1995–1997 1.7 1.2 3.4 1.5 0.8 2.8
1998–2000 2.2 1.1 3.3 1.5 1 2.6
leukemias 1988–1991 10.4 10.9 18 9.6 6.6 10.2
1992–1994 13.4 10.4 17.5 11.4 7 9.7
1995–1997 9.6 9.6 16.9 9 6.3 9.8
1998–2000 16.1 9.2 15.4 8.4 5.8 9
multiple myelomas 1988–1991 10.5 4.8 6.3 5.1 3.3 4.2
1992–1994 5.3 4.5 6.4 7.9 2.4 3.9
1995–1997 9.8 5.2 6.4 2.9 3.2 4.1
1998–2000 5.6 3.7 5.7 5.5 3 3.6
skin, excluding basal & squamous cell cancer 1988–1991 8.2 3.9 44.4 2.5 2 20.5
1992–1994 2.7 4.2 45.8 1.1 1.8 21.8
1995–1997 4.4 3.9 50 1.9 1.6 28.3
1998–2000 4 2.8 53.1 2.3 2.5 31.8
1 Rates are per 100,000 and age-adjusted to the U.S. 2000 standard population (5 year age-groups).
2 South Asian.
3 Asian/Pacific Islander.
4 white, non-Hispanic.
Table 3: Comparison of cancer rates1 in the SA2, API3 & NHW4 population of California, 1988–2000. (Continued)Page 9 of 13
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tion major risk factors include, late maternal age at first
parity (>30 years of age), having one child vs. 4, use of
oral contraceptives (OCs), use of hormone replacement
therapy (HRT), obesity and alcohol [58-60]. Adoption of
above-mentioned lifestyle practices by SA women and
inadequate screening could be related to the increase in
breast cancer in this population.
Cervical Cancer
Although HPV has been proposed as the first identified
necessary cause of cervical cancer [61,62], we attribute the
decreasing trend and very low IRRs of cervical cancer in
California SA women to screening success. California SA
women are getting screened at very early stages and hence
treated completely as compared to the Indian women
(cervical cancer ranks number one in India).
Ovarian and uterine cancers
Risk factors for epithelial ovarian cancer include older age,
being White, positive family history, nulliparity, infertil-
ity, and obesity (high saturated fat and carbohydrate
intake), postmenopausal HRT and use of cosmetic talc.
Conversely, preventive factors include OC use, vegetable
consumption, gravidity, lactation, tubal ligation, and hys-
terectomy. Genetic influence also plays a role, women
with mutations in the BRCA1 or BRCA2 genes having an
elevated risk [63-65]. Rates of this cancer in the SA women
are higher than the ASIAN/PIs and almost approximating
those of NHWs. Almost two-fold elevated risk of ovarian
cancer in California SA women compared to native Asian
Indian women can be explained by all the adoption of
above mentioned western life-style factors.
Similarly uterine/endometrial cancer is a disease of the
developed world. Epidemiological studies have shown
that majority of the incidence can be attributed to excess
body weight (in turn due to 'unopposed estrogens'), lack
of physical activity, exogenous hormones and chronic
hyperinsulinemia along with genetic predisposition
[66,67]. California SA women face a five-fold risk of this
cancer as compared to the native Asian Indians and they
show much higher rates than the Asian/PIs and their rates
seem to be fast approaching the NHWs of the state.
Clearly, acculturation can explain these findings.
Limitations
Certain limitations in the methods employed in this study
deserve comment. The assumption of a linear growth of
population may not be completely tenable, and various
factors such as birth/death rates and immigration/migra-
tion related issues could impact patterns of population
growth. However, communication with staff at the Los
Angeles County Cancer Surveillance program indicated
that interpolation performed well when compared to
more complex methods of estimation based on year/race/
ethnicity/sex and county specific population estimates
obtained from the California Department of Finance
(state agency in California charged with maintaining
intercensal population figures) [personal communica-
tion, Dr. Lihua Liu, USC/CSP, December, 2003].
While performing incidence studies on sub-ethnic popu-
lations, the issue of small number of cases is inevitable.
This could create instability of rates, especially in analyses
pertaining to trends over time. To overcome this, forming
groups and performing a grouped analysis in those groups
was completed.
Table 4: Comparison of rates1 of reproductive organ cancers in 
the SA2, API3 & NHW4 population of California.
Cancer site time period SA API NHW
MALES
prostate 1988–1991 112.5 78.2 165
1992–1994 127.8 109.4 197
1995–1997 111.8 90 153.2
1998–2000 110.7 87.9 152.2
testicular 1988–1991 1.5 1.5 6.5
1992–1994 2.2 1.9 6.5
1995–1997 0.8 1.6 6.4
1998–2000 1.9 1.9 7.1
FEMALES
breast (in situ) 1988–1991 8.1 10.2 19.9
1992–1994 14.1 12.3 21.7
1995–1997 13.2 17.1 25.3
1998–2000 14.6 21.6 29.4
breast (invasive) 1988–1991 75.2 76 144
1992–1994 75.5 79 142.3
1995–1997 97.6 87 146.5
1998–2000 98.1 91.9 150.8
ovary 1988–1991 14.3 12.9 19.5
1992–1994 15.1 13.3 19.3
1995–1997 19.4 13.4 18.2
1998–2000 15.1 12.2 18.2
cervix 1988–1991 11.7 14.7 9.3
1992–1994 12.1 15.8 8.6
1995–1997 9.5 13.1 8.4
1998–2000 10 9.8 7.9
uterus and corpus 1988–1991 17.8 13.9 28.1
1992–1994 19 14.8 27.1
1995–1997 11 14.8 27.1
1998–2000 22.2 15.9 25.3
1 Rates are per 100,000 and age-adjusted to the U.S. 2000 standard 
population (5 year age-groups).
2 south Asian.
3 Asian/Pacific Islander.
4 white, non-Hispanic.Page 10 of 13
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Our findings are in general agreement with studies com-
pleted in the UK and suggest a strong role for accultura-
tion, screening and lifestyle factors in explaining the
patterns of cancer in SA in California. Minor disagree-
ments with findings in UK studies are to be expected, as
there are minor underlying differences in methodology.
For example, some studies have used absolute numbers
for comparison or a proportionate approach for compari-
son. But most of the studies have reported incidence rates
based on data available from the cancer registries and cen-
sus bureaus/corresponding organizations in UK (with
whom we have compared our data).
More studies are needed to evaluate gender differences in
this population, especially the rising trend of gastrointes-
tinal cancers seen in SA females vs. males, needs more
investigation. Our study also reveals the need for addi-
tional screening measures and early diagnosis in this pop-
ulation. Our overall impression is that, if measures are not
taken to improve screening, and curb smoking in this
population and if the current conditions prevail, the rates
of colon, lung, and breast cancer in the SA population will
approximate those of California NHWs.
We have presented a general picture of cancer in the SA
population in this paper. It is beyond the scope of this
paper to discuss subtypes of each cancer. Hence we con-
clude that more studies are needed on this issue and sub-
type analysis of cancer sites needs to be conducted.
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Table 5: Table showing annual percentage change along with significance in cancer sites in the SA population of California, 1988–2000.
SITE MALE FEMALE
APC* P-VALUE APC P-VALUE
All Sites -1.0 0.2 0.9 0.4
common cancers
Oral Cavity and Pharynx -3.0 0.5 -4.0 0.1
Esophagus -1.3 0.9 7.2 0.3
Stomach -1.9 0.5 5.6 0.3
Liver and Intrahepatic Bile Duct 2.1 0.7 1.2 0.86
Gallbladder ~ ~ -9.9 0.1
Pancreas 3.5 0.5 -1.2 0.8
Colon and Rectum -1.3 0.3 3.5 0.3
Colon excluding Rectum -3.2 0.1 11.2* <0.05
Lung and Bronchus -2.9 0.3 0.8 0.8
Skin excluding Basal & Squamous -9.3 0.1 ~ ~
Urinary Bladder 0 1 ~ ~
Kidney and Renal Pelvis 8.1 0.2 ~ ~
Brain and other CNS -1.4 0.7
NHL 6 0.1 0.8 0.9
multiple myelomas -2.8 0.6 0.6 0.9
leukemias 2.6 0.5 -0.1 1
Thyroid ~ ~ -1.1 0.8
Reproductive organ cancers
Breast (In situ) ~ ~ 8.8* <0.05
Breast (Inavasive) ~ ~ 2.3 0.2
Cervix Uteri ~ ~ -2.1 0.3
Corpus and Uterus ~ ~ 1 0.8
Ovary ~ ~ -0.2 0.9
Prostate -0.5 0.6 ~ ~
* Annual Percentage change, numbers in red indicate significant p-values.
~ Annaul percentage change could not be calculated.Page 11 of 13
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